DALLAS, April 12, 2013 / TheNewswire / — X-Change Corp. (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation based health and wellness solutions, is proud to announce the appointment of Greta Gaines to its Board of Advisors. A noted Country singer and songwriter, Ms. Gaines will bring instrumental exposure for Phytiva branding, marketing, and product development.
Greta Gaines is a leading advocate on the reform of cannabinoid law, spending years becoming an authority while serving on the Board of Directors of the National Organization to Reform Marijuana Law (NORML); the Board of the NORML Women’s Alliance Foundation (as a Founding Member); and the Advisory Board of Patients Out of Time. Ms. Gaines is well known as an innovator in the use of hemp and developer of cannabinoid-based solutions as a valuable and healing commodity.
Ms. Gaines’ opinions are nationally respected in the industry and beyond. She routinely speaks at national industry and advocacy conventions, including a group assembled outside the Democratic National Convention. Ms. Gaines often speaks of the historical relevance of hemp and how it can positively impact the American economy on a number of levels, from farming to product development and sales. Women are believed to purchase as much as 80% of household products. This makes Ms. Gaines’ renowned voice in the market vital to the Company, as the Company believes that women will be the first to invest in and use Phytiva products. In addition, Ms. Gaines has independently tested many of the available hemp products throughout the world and therefore can assist in a wide range of Company projects.
“Greta and I have worked together on several industry projects over many years, and we are proud and privileged to have her as part of the team. Greta captivates everyone from individuals to large audiences with her extraordinary industry expertise and related endeavors. As a member of the Company’s Board of Advisors, Greta will undoubtedly play a large role in establishing Phytiva in the female driven market and help make Phytiva a household name,” stated Robert Kane, President and CEO of X-Change Corp.
About Phytiva Brand Product Lines
X-Change Corp. expects to develop and launch various innovative Phytiva Brand product lines. The first is the Phytiva Brand European Line, which is an inventive line that is a hybrid of a proven, existing product line that has been well-managed and conservatively-run for over a decade with a Cannabinoid based product line, utilizing the unique and potent benefits of Cannabinoids. Phytiva’s revolutionary formulations target not just the symptom, but also the cause. Cannabinoids and their sources constitute an ideal base for therapeutic solutions and have been utilized for centuries in skin and other remedies.
About The X-Change Corporation
X-Change Corp. is U.S. boutique Company whose niche is cannabinoid based extracts and products that target critical ailment, cosmeceutical, nutraceutical, and social usage solutions through multiple Phytiva Brand product lines, products, and services. These new Phytiva lines will be launched with cannabinoid based formulations through the launching of a combination of retail and wholesale products, medical cannabis dispensaries, cannabis research in clinics and laboratories, and other legal state and foreign grow operations, on a jurisdiction by jurisdiction approved basis.
Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as “anticipate,” “seek,” intend,” “believe,” “plan,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabinoid-based products. X-Change Corp. does not undertake any duty or does not intend to update the results of these forward-looking statements.
President & CEO